ERNA vs LOW · P/E 0.0, rev $582.0K vs P/E 18, rev $86.29B
Eterna Therapeutics Inc (ERNA) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the ERNA and LOW stock pages for the full models.
Not investment advice.